ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Luvit123
|
118 |
22K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
118
|
22K
|
0
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Luvit123
|
118 |
22K |
2 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
118
|
22K
|
2
|
|
ASX - By Stock
|
TRP |
Re:
Tissue Repair: Hidden Gem in Biotech!
|
|
Luvit123
|
118 |
22K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
118
|
22K
|
5
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Luvit123
|
47 |
7.6K |
2 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
47
|
7.6K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Ceasing to be a substantial holder
|
|
Luvit123
|
3 |
2K |
6 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
3
|
2K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ isolates brain-derived exosomes in Alzheimer's
|
|
Luvit123
|
7 |
3.3K |
22 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
7
|
3.3K
|
22
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
Luvit123
|
33 |
11K |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
33
|
11K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. budget pushes for action on screening for Veterans
|
|
Luvit123
|
25 |
12K |
12 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
25
|
12K
|
12
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Luvit123
|
16 |
3.2K |
1 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
16
|
3.2K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
229
|
123K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
9 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
229
|
123K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
229
|
123K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Investor Presentation Imbio acquisition and capital raise
|
|
Luvit123
|
91 |
33K |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
91
|
33K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM Recording
|
|
Luvit123
|
43 |
17K |
11 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
43
|
17K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.6K |
1.1M |
19 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
2.6K
|
1.1M
|
19
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM Recording
|
|
Luvit123
|
43 |
17K |
1 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
28 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
229
|
123K
|
28
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Luvit123
|
153 |
49K |
5 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
153
|
49K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Luvit123
|
153 |
49K |
10 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
153
|
49K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Luvit123
|
153 |
49K |
18 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
153
|
49K
|
18
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DX signs SaaS contracts to expand into Detroit & Memphis
|
|
Luvit123
|
153 |
49K |
21 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
153
|
49K
|
21
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: ANSEV Meeting Presentations
|
|
Luvit123
|
9 |
3.6K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
9
|
3.6K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
10 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
229
|
123K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2024
|
|
Luvit123
|
22 |
7.9K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
22
|
7.9K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
5 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
229
|
123K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.6K |
1.1M |
11 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
2.6K
|
1.1M
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.6K |
1.1M |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
2.6K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Luvit123
|
792 |
360K |
3 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
792
|
360K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
Luvit123
|
792 |
360K |
6 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
792
|
360K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: EXO-OC PROGRAM COMPLETES SERUM EQUIVALENCE STUDY
|
|
Luvit123
|
13 |
6.4K |
15 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
13
|
6.4K
|
15
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega announce Global Joint Marketing Agreement
|
|
Luvit123
|
40 |
19K |
10 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
40
|
19K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega announce Global Joint Marketing Agreement
|
|
Luvit123
|
40 |
19K |
28 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
40
|
19K
|
28
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
|
|
Luvit123
|
69 |
28K |
21 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
69
|
28K
|
21
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
|
|
Luvit123
|
69 |
28K |
10 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
69
|
28K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
|
|
Luvit123
|
69 |
28K |
19 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
69
|
28K
|
19
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SubB2M/CA15.3 Clinical Validation Data Investor Presentation
|
|
Luvit123
|
69 |
28K |
21 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
69
|
28K
|
21
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
18 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
229
|
123K
|
18
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
11 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
229
|
123K
|
11
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
|
|
Luvit123
|
39 |
17K |
18 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
39
|
17K
|
18
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
14 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
229
|
123K
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Luvit123
|
229 |
123K |
25 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
229
|
123K
|
25
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Change of Director's Interest Notice - Philip Powell
|
|
Luvit123
|
14 |
7.3K |
5 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
14
|
7.3K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial pilot with US Dept of Defense
|
|
Luvit123
|
52 |
20K |
16 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
52
|
20K
|
16
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C and Quarterly Activities Report - March 2023
|
|
Luvit123
|
2 |
2.1K |
14 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
2
|
2.1K
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: MST Access Diagnostics Forum Presentation
|
|
Luvit123
|
5 |
3.0K |
7 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
5
|
3.0K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: CEO AGM Presentation
|
|
Luvit123
|
8 |
3.6K |
6 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
8
|
3.6K
|
6
|
|
ASX - By Stock
|
TRP |
Re:
Ann: AGM Presentation
|
|
Luvit123
|
4 |
1.4K |
3 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
4
|
1.4K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.6K |
1.1M |
14 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
2.6K
|
1.1M
|
14
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.6K |
1.1M |
14 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
2.6K
|
1.1M
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Healthcare Conference Investor Presentation
|
|
Luvit123
|
16 |
8.4K |
17 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
16
|
8.4K
|
17
|
|